“bluebird-bio” Archives

Entry Author Date Location
Waving White Flag, Celladon Merges With Rare Disease Co. Eiger Bio 11/19/15 San Diego
East Coast Biotech Roundup: Bluebird, Solid GT, Evelo, Dyax & More 11/09/15 Boston
New Bluebird Data Hint at Gene Therapy’s Limits For Some Patients 11/05/15 Boston
Despite Sanofi’s Help, MyoKardia Prices IPO Below Expectations 10/29/15 San Francisco
East Coast Biotech Roundup: Cancer Vaccines, Biogen, LabCentral & More 10/23/15 Boston
Gene Therapy Startup Dimension Cuts Price But Bags $72M in IPO 10/21/15 Boston
Five Prime, Bristol Shake Hands Again in New $350M Cancer Pact 10/15/15 San Francisco
Voyager Charts an IPO Course Amid Choppy Biotech Waters 10/11/15 Boston
Amid Biotech Swoon, Third Rock’s MyoKardia Tees up IPO 09/28/15 San Francisco
East Coast Biotech Roundup: Biogen, Watson, Data Dumps & More 09/11/15 Boston
East Coast Biotech Roundup: WaVe, Shkreli, Intarcia & More 08/21/15 Boston
100 Years But Only One Drug: Sickle Cell Patients Wait For Help 08/18/15 National
In Biotech, Everyone’s Going Public. What’s Your Excuse? 07/22/15 National
Tackling Sickle Cell, Global Blood Therapeutics Joins IPO Queue 07/08/15 San Francisco
Celgene To Pay $1B For A Big Piece of Juno and T Cell Therapies 06/29/15 Seattle
West Coast Biotech Roundup: Bock, Celladon, Arivale, Conkwest & More 06/26/15 San Diego
East Coast Biotech Roundup: Flagship, SQZ, Epizyme, IPOs & More 06/26/15 Boston
East Coast Biotech Roundup: Emulate, Pulmatrix, Synergy & More 06/19/15 New York
East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More 06/12/15 Boston
Celgene, Bluebird Streamline CAR-T Partnership To Fight Myeloma 06/03/15 Boston
East Coast Biotech Roundup: Seres, Editas, PureTech, Pronutria & More 05/29/15 Boston
Bluebird Adds to CAR-T Arsenal With Five Prime Antibody Deal 05/26/15 Boston
East Coast Biotech Roundup: Bluebird, Sarepta, Synlogic & More 05/22/15 Boston
So Far, So Good in Bluebird’s First Glimpse of Sickle Cell Data 05/21/15 Boston
Bluebird, Regulators Map Out Approval Plan For Gene Therapy 05/19/15 Boston
Celgene, Versant Shake Again, Cut $30M Deal For Toronto Biotech 04/29/15 New York
Semma Secures $44M to Develop Diabetes Stem Cell Therapy 03/24/15 Boston
Epizyme Buys Back Control of Cancer Drug From Eisai For up to $110M 03/12/15 Boston
Bellicum CEO Reflects on Rise From Baylor to Houston Biotech Darling 02/26/15 Texas
Genzyme Buys into Neuro Gene Therapies With $845M Voyager Pact 02/11/15 Boston
Page 1 of 4 next page »